Clinical Classification and Prognosis of Isolated Right-Sided Infective Endocarditis

From an epidemiologic point of view, right-sided infective endocarditis (RSIE) affects different types of patients: intravenous drug users (IDUs), cardiac device carriers (pacemakers and implantable automatic defibrillators), and the "3 noes" endocarditis group: no left-sided, no IDUs, no...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Medicine (Baltimore) 2014-12, Vol.93 (27), p.e137-e137
Hauptverfasser: Ortiz, Carlos, López, Javier, García, Héctor, Sevilla, Teresa, Revilla, Ana, Vilacosta, Isidre, Sarriá, Cristina, Olmos, Carmen, Ferrera, Carlos, García, Pablo Elpidio, Sáez, Carmen, Gómez, Itziar, San Román, José Alberto
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e137
container_issue 27
container_start_page e137
container_title Medicine (Baltimore)
container_volume 93
creator Ortiz, Carlos
López, Javier
García, Héctor
Sevilla, Teresa
Revilla, Ana
Vilacosta, Isidre
Sarriá, Cristina
Olmos, Carmen
Ferrera, Carlos
García, Pablo Elpidio
Sáez, Carmen
Gómez, Itziar
San Román, José Alberto
description From an epidemiologic point of view, right-sided infective endocarditis (RSIE) affects different types of patients: intravenous drug users (IDUs), cardiac device carriers (pacemakers and implantable automatic defibrillators), and the "3 noes" endocarditis group: no left-sided, no IDUs, no cardiac devices. Our objective is to describe and compare the clinical profile and outcome of these groups of patients. Every episode of infective endocarditis (IE) consecutively diagnosed in 3 tertiary centers from 1996 to 2012 was included in an ongoing multipurpose database. We assessed 85 epidemiologic, clinical, echocardiographic, and outcome variables in patients with isolated RSIE. A bivariated comparative analysis between the 3 groups was conducted.Among 866 IE episodes, 121 were classified as isolated RSIE (14%): 36 IDUs (30%), 65 cardiac device carriers (54%), and 20 "3 noes" group (16%). IDUs were mainly young men (36 ± 7 years) without previous heart disease, few comorbidities, and frequent previous endocarditis episodes (28%). Human immunodeficiency virus infection was frequent (69%). Cardiac device carriers were older (66 ± 15 years) and had less comorbidities (34%). Removal of the infected device was performed in 91% of the patients without any death. The "3 noes" endocarditis group was composed mainly by middle-age men (56 ± 18 years), health care related infections (50%), and had many comorbidities (75%). Whereas Staphylococcus aureus were the most frequent cause in IDUs (72% vs 34% in device carriers and 34% in the "3 noes" group, P = 0.001), coagulase negative Staphylococci predominated in the device carriers (58% vs 11% in drug users and 35% in the "3 noes", P < 0.001). Significant differences in mortality were found (17% in drug users, 3% in device carriers, and 30% in the "3 noes" group; P < 0.001). These results suggest that RSIE should be separated into 3 groups (IDUs, cardiac device carriers, and the "3 noes") and considered as independent entities as there are relevant epidemiologic, clinical, microbiological, echocardiographic, and prognostic differences among them.
doi_str_mv 10.1097/MD.0000000000000137
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4602814</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1637549772</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4506-26ee820fdaaceb5df25af12e42a7b7e1ad9575cc86b32ea09d24caf5a51cfa673</originalsourceid><addsrcrecordid>eNpdkU1vFDEMhiMEotvCL0BCc-QyJcnkY-eChLYfrNQKBOUceRNnN5BNSpJtxb9n2i1VwRdb9uPXll5C3jB6zOio31-eHNOnwQb9jMyYHFQvRyWekxmlXPZ61OKAHNb64x7h4iU54FJSRiWfkatFDClYiN0iQq3BT3ULOXWQXPel5HXKNdQu-25Zc4SGrvsa1pvWfwtuqpfJo23hBrvT5LKF4kIL9RV54SFWfP2Qj8j3s9Orxaf-4vP5cvHxordCUtVzhTjn1DsAiyvpPJfgGUfBQa80MnCj1NLauVoNHIGOjgsLXoJk1oPSwxH5sNe93q226CymViCa6xK2UH6bDMH8O0lhY9b5xghF-ZyJSeDdg0DJv3ZYm9mGajFGSJh31TA1aClGrfmEDnvUllxrQf94hlFz54e5PDH_-zFtvX364ePOXwMmQOyB2xwblvoz7m6xmA1CbJt7PalH3nPKBOOU0_6upYY_v9OXog</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1637549772</pqid></control><display><type>article</type><title>Clinical Classification and Prognosis of Isolated Right-Sided Infective Endocarditis</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Complete</source><source>Wolters Kluwer Open Health</source><source>IngentaConnect Free/Open Access Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Ortiz, Carlos ; López, Javier ; García, Héctor ; Sevilla, Teresa ; Revilla, Ana ; Vilacosta, Isidre ; Sarriá, Cristina ; Olmos, Carmen ; Ferrera, Carlos ; García, Pablo Elpidio ; Sáez, Carmen ; Gómez, Itziar ; San Román, José Alberto</creator><creatorcontrib>Ortiz, Carlos ; López, Javier ; García, Héctor ; Sevilla, Teresa ; Revilla, Ana ; Vilacosta, Isidre ; Sarriá, Cristina ; Olmos, Carmen ; Ferrera, Carlos ; García, Pablo Elpidio ; Sáez, Carmen ; Gómez, Itziar ; San Román, José Alberto</creatorcontrib><description>From an epidemiologic point of view, right-sided infective endocarditis (RSIE) affects different types of patients: intravenous drug users (IDUs), cardiac device carriers (pacemakers and implantable automatic defibrillators), and the "3 noes" endocarditis group: no left-sided, no IDUs, no cardiac devices. Our objective is to describe and compare the clinical profile and outcome of these groups of patients. Every episode of infective endocarditis (IE) consecutively diagnosed in 3 tertiary centers from 1996 to 2012 was included in an ongoing multipurpose database. We assessed 85 epidemiologic, clinical, echocardiographic, and outcome variables in patients with isolated RSIE. A bivariated comparative analysis between the 3 groups was conducted.Among 866 IE episodes, 121 were classified as isolated RSIE (14%): 36 IDUs (30%), 65 cardiac device carriers (54%), and 20 "3 noes" group (16%). IDUs were mainly young men (36 ± 7 years) without previous heart disease, few comorbidities, and frequent previous endocarditis episodes (28%). Human immunodeficiency virus infection was frequent (69%). Cardiac device carriers were older (66 ± 15 years) and had less comorbidities (34%). Removal of the infected device was performed in 91% of the patients without any death. The "3 noes" endocarditis group was composed mainly by middle-age men (56 ± 18 years), health care related infections (50%), and had many comorbidities (75%). Whereas Staphylococcus aureus were the most frequent cause in IDUs (72% vs 34% in device carriers and 34% in the "3 noes" group, P = 0.001), coagulase negative Staphylococci predominated in the device carriers (58% vs 11% in drug users and 35% in the "3 noes", P &lt; 0.001). Significant differences in mortality were found (17% in drug users, 3% in device carriers, and 30% in the "3 noes" group; P &lt; 0.001). These results suggest that RSIE should be separated into 3 groups (IDUs, cardiac device carriers, and the "3 noes") and considered as independent entities as there are relevant epidemiologic, clinical, microbiological, echocardiographic, and prognostic differences among them.</description><identifier>ISSN: 0025-7974</identifier><identifier>EISSN: 1536-5964</identifier><identifier>DOI: 10.1097/MD.0000000000000137</identifier><identifier>PMID: 25501052</identifier><language>eng</language><publisher>United States: The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Defibrillators, Implantable - microbiology ; Drug Users - statistics &amp; numerical data ; Echocardiography ; Endocarditis - diagnostic imaging ; Endocarditis - epidemiology ; Endocarditis - microbiology ; Female ; Humans ; Male ; Middle Aged ; Observational Study ; Pacemaker, Artificial - microbiology ; Prognosis ; Spain - epidemiology ; Tertiary Care Centers</subject><ispartof>Medicine (Baltimore), 2014-12, Vol.93 (27), p.e137-e137</ispartof><rights>The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved.</rights><rights>Copyright © 2014 Wolters Kluwer Health | Lippincott Williams &amp; Wilkins 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4506-26ee820fdaaceb5df25af12e42a7b7e1ad9575cc86b32ea09d24caf5a51cfa673</citedby><cites>FETCH-LOGICAL-c4506-26ee820fdaaceb5df25af12e42a7b7e1ad9575cc86b32ea09d24caf5a51cfa673</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602814/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602814/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25501052$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ortiz, Carlos</creatorcontrib><creatorcontrib>López, Javier</creatorcontrib><creatorcontrib>García, Héctor</creatorcontrib><creatorcontrib>Sevilla, Teresa</creatorcontrib><creatorcontrib>Revilla, Ana</creatorcontrib><creatorcontrib>Vilacosta, Isidre</creatorcontrib><creatorcontrib>Sarriá, Cristina</creatorcontrib><creatorcontrib>Olmos, Carmen</creatorcontrib><creatorcontrib>Ferrera, Carlos</creatorcontrib><creatorcontrib>García, Pablo Elpidio</creatorcontrib><creatorcontrib>Sáez, Carmen</creatorcontrib><creatorcontrib>Gómez, Itziar</creatorcontrib><creatorcontrib>San Román, José Alberto</creatorcontrib><title>Clinical Classification and Prognosis of Isolated Right-Sided Infective Endocarditis</title><title>Medicine (Baltimore)</title><addtitle>Medicine (Baltimore)</addtitle><description>From an epidemiologic point of view, right-sided infective endocarditis (RSIE) affects different types of patients: intravenous drug users (IDUs), cardiac device carriers (pacemakers and implantable automatic defibrillators), and the "3 noes" endocarditis group: no left-sided, no IDUs, no cardiac devices. Our objective is to describe and compare the clinical profile and outcome of these groups of patients. Every episode of infective endocarditis (IE) consecutively diagnosed in 3 tertiary centers from 1996 to 2012 was included in an ongoing multipurpose database. We assessed 85 epidemiologic, clinical, echocardiographic, and outcome variables in patients with isolated RSIE. A bivariated comparative analysis between the 3 groups was conducted.Among 866 IE episodes, 121 were classified as isolated RSIE (14%): 36 IDUs (30%), 65 cardiac device carriers (54%), and 20 "3 noes" group (16%). IDUs were mainly young men (36 ± 7 years) without previous heart disease, few comorbidities, and frequent previous endocarditis episodes (28%). Human immunodeficiency virus infection was frequent (69%). Cardiac device carriers were older (66 ± 15 years) and had less comorbidities (34%). Removal of the infected device was performed in 91% of the patients without any death. The "3 noes" endocarditis group was composed mainly by middle-age men (56 ± 18 years), health care related infections (50%), and had many comorbidities (75%). Whereas Staphylococcus aureus were the most frequent cause in IDUs (72% vs 34% in device carriers and 34% in the "3 noes" group, P = 0.001), coagulase negative Staphylococci predominated in the device carriers (58% vs 11% in drug users and 35% in the "3 noes", P &lt; 0.001). Significant differences in mortality were found (17% in drug users, 3% in device carriers, and 30% in the "3 noes" group; P &lt; 0.001). These results suggest that RSIE should be separated into 3 groups (IDUs, cardiac device carriers, and the "3 noes") and considered as independent entities as there are relevant epidemiologic, clinical, microbiological, echocardiographic, and prognostic differences among them.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Defibrillators, Implantable - microbiology</subject><subject>Drug Users - statistics &amp; numerical data</subject><subject>Echocardiography</subject><subject>Endocarditis - diagnostic imaging</subject><subject>Endocarditis - epidemiology</subject><subject>Endocarditis - microbiology</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Observational Study</subject><subject>Pacemaker, Artificial - microbiology</subject><subject>Prognosis</subject><subject>Spain - epidemiology</subject><subject>Tertiary Care Centers</subject><issn>0025-7974</issn><issn>1536-5964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkU1vFDEMhiMEotvCL0BCc-QyJcnkY-eChLYfrNQKBOUceRNnN5BNSpJtxb9n2i1VwRdb9uPXll5C3jB6zOio31-eHNOnwQb9jMyYHFQvRyWekxmlXPZ61OKAHNb64x7h4iU54FJSRiWfkatFDClYiN0iQq3BT3ULOXWQXPel5HXKNdQu-25Zc4SGrvsa1pvWfwtuqpfJo23hBrvT5LKF4kIL9RV54SFWfP2Qj8j3s9Orxaf-4vP5cvHxordCUtVzhTjn1DsAiyvpPJfgGUfBQa80MnCj1NLauVoNHIGOjgsLXoJk1oPSwxH5sNe93q226CymViCa6xK2UH6bDMH8O0lhY9b5xghF-ZyJSeDdg0DJv3ZYm9mGajFGSJh31TA1aClGrfmEDnvUllxrQf94hlFz54e5PDH_-zFtvX364ePOXwMmQOyB2xwblvoz7m6xmA1CbJt7PalH3nPKBOOU0_6upYY_v9OXog</recordid><startdate>20141201</startdate><enddate>20141201</enddate><creator>Ortiz, Carlos</creator><creator>López, Javier</creator><creator>García, Héctor</creator><creator>Sevilla, Teresa</creator><creator>Revilla, Ana</creator><creator>Vilacosta, Isidre</creator><creator>Sarriá, Cristina</creator><creator>Olmos, Carmen</creator><creator>Ferrera, Carlos</creator><creator>García, Pablo Elpidio</creator><creator>Sáez, Carmen</creator><creator>Gómez, Itziar</creator><creator>San Román, José Alberto</creator><general>The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved</general><general>Wolters Kluwer Health</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20141201</creationdate><title>Clinical Classification and Prognosis of Isolated Right-Sided Infective Endocarditis</title><author>Ortiz, Carlos ; López, Javier ; García, Héctor ; Sevilla, Teresa ; Revilla, Ana ; Vilacosta, Isidre ; Sarriá, Cristina ; Olmos, Carmen ; Ferrera, Carlos ; García, Pablo Elpidio ; Sáez, Carmen ; Gómez, Itziar ; San Román, José Alberto</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4506-26ee820fdaaceb5df25af12e42a7b7e1ad9575cc86b32ea09d24caf5a51cfa673</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Defibrillators, Implantable - microbiology</topic><topic>Drug Users - statistics &amp; numerical data</topic><topic>Echocardiography</topic><topic>Endocarditis - diagnostic imaging</topic><topic>Endocarditis - epidemiology</topic><topic>Endocarditis - microbiology</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Observational Study</topic><topic>Pacemaker, Artificial - microbiology</topic><topic>Prognosis</topic><topic>Spain - epidemiology</topic><topic>Tertiary Care Centers</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ortiz, Carlos</creatorcontrib><creatorcontrib>López, Javier</creatorcontrib><creatorcontrib>García, Héctor</creatorcontrib><creatorcontrib>Sevilla, Teresa</creatorcontrib><creatorcontrib>Revilla, Ana</creatorcontrib><creatorcontrib>Vilacosta, Isidre</creatorcontrib><creatorcontrib>Sarriá, Cristina</creatorcontrib><creatorcontrib>Olmos, Carmen</creatorcontrib><creatorcontrib>Ferrera, Carlos</creatorcontrib><creatorcontrib>García, Pablo Elpidio</creatorcontrib><creatorcontrib>Sáez, Carmen</creatorcontrib><creatorcontrib>Gómez, Itziar</creatorcontrib><creatorcontrib>San Román, José Alberto</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Medicine (Baltimore)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ortiz, Carlos</au><au>López, Javier</au><au>García, Héctor</au><au>Sevilla, Teresa</au><au>Revilla, Ana</au><au>Vilacosta, Isidre</au><au>Sarriá, Cristina</au><au>Olmos, Carmen</au><au>Ferrera, Carlos</au><au>García, Pablo Elpidio</au><au>Sáez, Carmen</au><au>Gómez, Itziar</au><au>San Román, José Alberto</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical Classification and Prognosis of Isolated Right-Sided Infective Endocarditis</atitle><jtitle>Medicine (Baltimore)</jtitle><addtitle>Medicine (Baltimore)</addtitle><date>2014-12-01</date><risdate>2014</risdate><volume>93</volume><issue>27</issue><spage>e137</spage><epage>e137</epage><pages>e137-e137</pages><issn>0025-7974</issn><eissn>1536-5964</eissn><abstract>From an epidemiologic point of view, right-sided infective endocarditis (RSIE) affects different types of patients: intravenous drug users (IDUs), cardiac device carriers (pacemakers and implantable automatic defibrillators), and the "3 noes" endocarditis group: no left-sided, no IDUs, no cardiac devices. Our objective is to describe and compare the clinical profile and outcome of these groups of patients. Every episode of infective endocarditis (IE) consecutively diagnosed in 3 tertiary centers from 1996 to 2012 was included in an ongoing multipurpose database. We assessed 85 epidemiologic, clinical, echocardiographic, and outcome variables in patients with isolated RSIE. A bivariated comparative analysis between the 3 groups was conducted.Among 866 IE episodes, 121 were classified as isolated RSIE (14%): 36 IDUs (30%), 65 cardiac device carriers (54%), and 20 "3 noes" group (16%). IDUs were mainly young men (36 ± 7 years) without previous heart disease, few comorbidities, and frequent previous endocarditis episodes (28%). Human immunodeficiency virus infection was frequent (69%). Cardiac device carriers were older (66 ± 15 years) and had less comorbidities (34%). Removal of the infected device was performed in 91% of the patients without any death. The "3 noes" endocarditis group was composed mainly by middle-age men (56 ± 18 years), health care related infections (50%), and had many comorbidities (75%). Whereas Staphylococcus aureus were the most frequent cause in IDUs (72% vs 34% in device carriers and 34% in the "3 noes" group, P = 0.001), coagulase negative Staphylococci predominated in the device carriers (58% vs 11% in drug users and 35% in the "3 noes", P &lt; 0.001). Significant differences in mortality were found (17% in drug users, 3% in device carriers, and 30% in the "3 noes" group; P &lt; 0.001). These results suggest that RSIE should be separated into 3 groups (IDUs, cardiac device carriers, and the "3 noes") and considered as independent entities as there are relevant epidemiologic, clinical, microbiological, echocardiographic, and prognostic differences among them.</abstract><cop>United States</cop><pub>The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved</pub><pmid>25501052</pmid><doi>10.1097/MD.0000000000000137</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0025-7974
ispartof Medicine (Baltimore), 2014-12, Vol.93 (27), p.e137-e137
issn 0025-7974
1536-5964
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4602814
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Complete; Wolters Kluwer Open Health; IngentaConnect Free/Open Access Journals; PubMed Central; Alma/SFX Local Collection
subjects Adult
Aged
Aged, 80 and over
Defibrillators, Implantable - microbiology
Drug Users - statistics & numerical data
Echocardiography
Endocarditis - diagnostic imaging
Endocarditis - epidemiology
Endocarditis - microbiology
Female
Humans
Male
Middle Aged
Observational Study
Pacemaker, Artificial - microbiology
Prognosis
Spain - epidemiology
Tertiary Care Centers
title Clinical Classification and Prognosis of Isolated Right-Sided Infective Endocarditis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T23%3A24%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20Classification%20and%20Prognosis%20of%20Isolated%20Right-Sided%20Infective%20Endocarditis&rft.jtitle=Medicine%20(Baltimore)&rft.au=Ortiz,%20Carlos&rft.date=2014-12-01&rft.volume=93&rft.issue=27&rft.spage=e137&rft.epage=e137&rft.pages=e137-e137&rft.issn=0025-7974&rft.eissn=1536-5964&rft_id=info:doi/10.1097/MD.0000000000000137&rft_dat=%3Cproquest_pubme%3E1637549772%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1637549772&rft_id=info:pmid/25501052&rfr_iscdi=true